560 related articles for article (PubMed ID: 33585706)
1. Can
Nagoor Meeran MF; Javed H; Sharma C; Goyal SN; Kumar S; Jha NK; Ojha S
Heliyon; 2021 Feb; 7(2):e05990. PubMed ID: 33585706
[TBL] [Abstract][Full Text] [Related]
2. β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19.
Jha NK; Sharma C; Hashiesh HM; Arunachalam S; Meeran MN; Javed H; Patil CR; Goyal SN; Ojha S
Front Pharmacol; 2021; 12():590201. PubMed ID: 34054510
[TBL] [Abstract][Full Text] [Related]
3. Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19?
Nagoor Meeran MF; Seenipandi A; Javed H; Sharma C; Hashiesh HM; Goyal SN; Jha NK; Ojha S
Heliyon; 2021 Jan; 7(1):e05703. PubMed ID: 33490659
[TBL] [Abstract][Full Text] [Related]
4. CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections.
Nagoor Meeran MF; Sharma C; Goyal SN; Kumar S; Ojha S
Drug Dev Res; 2021 Feb; 82(1):7-11. PubMed ID: 33190277
[TBL] [Abstract][Full Text] [Related]
5. An overview of possible pivotal mechanisms of Genistein as a potential phytochemical against SARS-CoV-2 infection: A hypothesis.
Jafari A; Esmaeilzadeh Z; Khezri MR; Ghasemnejad-Berenji H; Pashapour S; Sadeghpour S; Ghasemnejad-Berenji M
J Food Biochem; 2022 Oct; 46(10):e14345. PubMed ID: 35866873
[TBL] [Abstract][Full Text] [Related]
6.
Kolev E; Mircheva L; Edwards MR; Johnston SL; Kalinov K; Stange R; Gancitano G; Berghe WV; Kreft S
Front Pharmacol; 2022; 13():856410. PubMed ID: 35559249
[TBL] [Abstract][Full Text] [Related]
7. Echinacea purpurea (L.) Moench treatment of monocytes promotes tonic interferon signaling, increased innate immunity gene expression and DNA repeat hypermethylated silencing of endogenous retroviral sequences.
Declerck K; Novo CP; Grielens L; Van Camp G; Suter A; Vanden Berghe W
BMC Complement Med Ther; 2021 May; 21(1):141. PubMed ID: 33980308
[TBL] [Abstract][Full Text] [Related]
8. In vitro screening of anti-viral and virucidal effects against SARS-CoV-2 by Hypericum perforatum and Echinacea.
Bajrai LH; El-Kafrawy SA; Hassan AM; Tolah AM; Alnahas RS; Sohrab SS; Rehan M; Azhar EI
Sci Rep; 2022 Dec; 12(1):21723. PubMed ID: 36522420
[TBL] [Abstract][Full Text] [Related]
9. Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
Xiang J; Lu M; Shi M; Cheng X; Kwakwa KA; Davis JL; Su X; Bakewell SJ; Zhang Y; Fontana F; Xu Y; Veis DJ; DiPersio JF; Ratner L; Sanderson RD; Noseda A; Mollah S; Li J; Weilbaecher KN
J Virol; 2022 Apr; 96(7):e0005722. PubMed ID: 35319225
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
11. The landscape of potential health benefits of carotenoids as natural supportive therapeutics in protecting against Coronavirus infection.
Lu LW; Gao Y; Quek SY; Foster M; Eason CT; Liu M; Wang M; Chen JH; Chen F
Biomed Pharmacother; 2022 Oct; 154():113625. PubMed ID: 36058151
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
13. The effect of
Aucoin M; Cooley K; Saunders PR; Carè J; Anheyer D; Medina DN; Cardozo V; Remy D; Hannan N; Garber A
Adv Integr Med; 2020 Dec; 7(4):203-217. PubMed ID: 32837894
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
Rossi F; Tortora C; Argenziano M; Di Paola A; Punzo F
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471272
[TBL] [Abstract][Full Text] [Related]
15. Traditional herbs against COVID-19: back to old weapons to combat the new pandemic.
Al-Kuraishy HM; Al-Fakhrany OM; Elekhnawy E; Al-Gareeb AI; Alorabi M; De Waard M; Albogami SM; Batiha GE
Eur J Med Res; 2022 Sep; 27(1):186. PubMed ID: 36154838
[TBL] [Abstract][Full Text] [Related]
16. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
17. A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.
Rocha SM; Fagre AC; Latham AS; Cummings JE; Aboellail TA; Reigan P; Aldaz DA; McDermott CP; Popichak KA; Kading RC; Schountz T; Theise ND; Slayden RA; Tjalkens RB
Front Immunol; 2022; 13():811430. PubMed ID: 35250984
[TBL] [Abstract][Full Text] [Related]
18. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Malekmohammad K; Rafieian-Kopaei M
Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
[TBL] [Abstract][Full Text] [Related]
20. Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.
Schijns V; Lavelle EC
Eur J Immunol; 2020 Jul; 50(7):932-938. PubMed ID: 32438473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]